| Long name | 1) Monoclonal Antibody, 3, 4, TGFB2 (220ct16 |
| Also known as | 1) Monoclonal Antibody, 3, 4, TGFB2 (220ct16 |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | TGFB2 |
| Specificity | This is a highly specific antibody against TGFB2 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Monoclonal |
| Clone number | 1, 220ct16, 3, 4 |
| Source | This TGFB2 monoclonal antibody is generated from mouse immunized with TGFB2 recombinant protein |
| Gene ID number | 7042 |
| Swiss Prot | P61812 |
| Tested Applications | IF, IHC-P, WB |
| Recommended dilutions | IHC-P (1:10~50), WB (1:500-1000) |
| Cross reactivity | Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | TGF-beta 2 has suppressive effects on interleukin-2 dependent T-cell growth |
| Purification method | This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS, 09% (W/V) sodium azide, Purified monoclonal antibody supplied in PBS with 0 |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | BSC-1 cell growth inhibitor, Cetermin, G-TSF, Glioblastoma-derived T-cell suppressor factor, Polyergin, TGF-beta-2, TGF-beta2, TGFB2, Transforming growth factor beta-2, LDS4 |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| About | Each murine monoclonal anibody has his own affinity specific for the clone, Mouse monoclonal antibodies are purified protein A or G and can be conjugated to FITC for flow cytometry or FACS and can be of different isotypes, Monoclonals of this antigen are available in different clones |
| Gene target | 1) Monoclonal, 3, 4, TGFB2 (220ct16 |
| Short name | 1) Monoclonal Antibody, 3, 4, TGFB2 (220ct16 |
| Technique | Monoclonals or monoclonal antibodies, antibodies against human proteins, antibodies for, Antibody |
| Alternative name | b 2 (220ct16, 1) monoclonal (Antibody to), 3, 4, transforming growth factor |
| Alternative technique | antibodies |
| Alternative to gene target | Extracellular, LDS4 and TGF-beta2, TGFB2 and IDBG-106710 and ENSG00000092969 and 7042, TGFB2 and IDBG-629908 and ENSBTAG00000005359 and 534069, Tgfb2 and IDBG-208111 and ENSMUSG00000039239 and 21808, beta 2, protein heterodimerization activity, this GO :0000902 and cell morphogenesis and biological process this GO :0001501 and skeletal system development and biological process this GO :0001502 and cartilage condensation and biological process this GO :0001525 and angiogenesis and biological process this GO :0001540 and beta-amyloid binding and molecular function this GO :0001568 and blood vessel development and biological process this GO :0001654 and eye development and biological process this GO :0001666 and response to hypoxia and biological process this GO :0001837 and epithelial to mesenchymal transition and biological process this GO :0001942 and hair follicle development and biological process this GO :0001974 and blood vessel remodeling and biological process this GO :0002576 and platelet degranulation and biological process this GO :0003007 and heart morphogenesis and biological process this GO :0004702 and receptor signaling protein serine/threonine kinase activity and molecular function this GO :0005102 and receptor binding and molecular function this GO :0005114 and type II transforming growth factor beta receptor binding and molecular function this GO :0005125 and cytokine activity and molecular function this GO :0005160 and transforming growth factor beta receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005768 and endosome and cellular component this GO :0006468 and protein phosphorylation and biological process this GO :0007050 and cell cycle arrest and biological process this GO :0007179 and transforming growth factor beta receptor signaling pathway and biological process this GO :0007184 and SMAD protein import into nucleus and biological process this GO :0007267 and cell-cell signaling and biological process this GO :0007411 and axon guidance and biological process this GO :0007435 and salivary gland morphogenesis and biological process this GO :0007507 and heart development and biological process this GO :0007596 and blood coagulation and biological process this GO :0008083 and growth factor activity and molecular function this GO :0008219 and cell death and biological process this GO :0008283 and cell proliferation and biological process this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0008285 and negative regulation of cell proliferation and biological process this GO :0008347 and glial cell migration and biological process this GO :0009611 and response to wounding and biological process this GO :0009790 and embryo development and biological process this GO :0010002 and cardioblast differentiation and biological process this GO :0010628 and positive regulation of gene expression and biological process this GO :0010634 and positive regulation of epithelial cell migration and biological process this GO :0010693 and negative regulation of alkaline phosphatase activity and biological process this GO :0010718 and positive regulation of epithelial to mesenchymal transition and biological process this GO :0010936 and negative regulation of macrophage cytokine production and biological process this GO :0014068 and positive regulation of phosphatidylinositol 3-kinase signaling and biological process this GO :0016049 and cell growth and biological process this GO :0016477 and cell migration and biological process this GO :0022601 and menstrual cycle phase and biological process this GO :0023014 and signal transduction by phosphorylation and biological process this GO :0030097 and hemopoiesis and biological process this GO :0030168 and platelet activation and biological process this GO :0030198 and extracellular matrix organization and biological process this GO :0030199 and collagen fibril organization and biological process this GO :0030307 and positive regulation of cell growth and biological process this GO :0030308 and negative regulation of cell growth and biological process this GO :0030424 and axon and cellular component this GO :0030593 and neutrophil chemotaxis and biological process this GO :0031012 and extracellular matrix and cellular component this GO :0031069 and hair follicle morphogenesis and biological process this GO :0031093 and platelet alpha granule lumen and cellular component this GO :0032147 and activation of protein kinase activity and biological process this GO :0032570 and response to progesterone and biological process this GO :0032874 and positive regulation of stress-activated MAPK cascade and biological process this GO :0032909 and regulation of transforming growth factor beta2 production and biological process this GO :0033630 and positive regulation of cell adhesion mediated by integrin and biological process this GO :0040007 and growth and biological process this GO :0042060 and wound healing and biological process this GO :0042416 and dopamine biosynthetic process and biological process this GO :0042476 and odontogenesis and biological process this GO :0042493 and response to drug and biological process this GO :0042637 and catagen and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0042981 and regulation of apoptotic process and biological process this GO :0043025 and neuronal cell body and cellular component this GO :0043525 and positive regulation of neuron apoptotic process and biological process this GO :0045216 and cell-cell junction organization and biological process this GO :0045726 and positive regulation of integrin biosynthetic process and biological process this GO :0045778 and positive regulation of ossification and biological process this GO :0045787 and positive regulation of cell cycle and biological process this GO :0045823 and positive regulation of heart contraction and biological process this GO :0046982 and protein heterodimerization activity and molecular function this GO :0048103 and somatic stem cell division and biological process this GO :0048566 and embryonic digestive tract development and biological process this GO :0048663 and neuron fate commitment and biological process this GO :0048666 and neuron development and biological process this GO :0048699 and generation of neurons and biological process this GO :0050680 and negative regulation of epithelial cell proliferation and biological process this GO :0050714 and positive regulation of protein secretion and biological process this GO :0050777 and negative regulation of immune response and biological process this GO :0050778 and positive regulation of immune response and biological process this GO :0051781 and positive regulation of cell division and biological process this GO :0051795 and positive regulation of catagen and biological process this GO :0051891 and positive regulation of cardioblast differentiation and biological process this GO :0060038 and cardiac muscle cell proliferation and biological process this GO :0060317 and cardiac epithelial to mesenchymal transition and biological process this GO :0060325 and face morphogenesis and biological process this GO :0060389 and pathway-restricted SMAD protein phosphorylation and biological process this GO :0070237 and positive regulation of activation-induced cell death of T cells and biological process this GO :0097191 and extrinsic apoptotic signaling pathway and biological process this GO :2001241 and positive regulation of extrinsic apoptotic signaling pathway in absence of ligand and biological process, this GO :0001540: beta-amyloid binding, this GO :0001540: beta-amyloid binding and also this GO :0004702: receptor signaling protein serine/threonine kinase activity and also this GO :0005102: receptor binding and also this GO :0005114: type II transforming growth factor beta receptor binding and also this GO :0005125: cytokine activity and also this GO :0005160: transforming growth factor beta receptor binding and also this GO :0005515: protein binding and also this GO :0008083: growth factor activity and also this GO :0042803: protein homodimerization activity and also this GO :0046982: protein heterodimerization activity, this GO :0004702: receptor signaling protein serine/threonine kinase activity, this GO :0005102: receptor binding, this GO :0005114: type II transforming growth factor beta receptor binding, this GO :0005125: cytokine activity, this GO :0005160: transforming growth factor beta receptor binding, this GO :0005515: protein binding, this GO :0008083: growth factor activity, this GO :0042803: protein homodimerization activity, this GO :0046982: protein heterodimerization activity, transforming growth factor |
| Identity | 11768 |
| Gene | TGFB2 |
| Long gene name | transforming growth factor beta 2 |
| Synonyms gene name | beta 2 , transforming growth factor |
| Synonyms name | prepro-transforming growth factor beta-2 |
| Locus | 1q41 |
| Discovery year | 1989-05-10 |
| GenBank acession | M19154 |
| Entrez gene record | 7042 |
| RefSeq identity | NM_003238 |
| Classification | Endogenous ligands |
| Havana BLAST/BLAT | OTTHUMG00000039521 |
Technique
Supplier
Species
Label
Iso Type
Host
Tissue